BPTH — Bio Path Holdings Share News
0.000.00%
Last trade - 00:00Brief: Bio-Path Holdings Reports Full Year 2024 Financial Results
Brief: Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
Brief: Bio-Path Provides Key Clinical Updates
Brief: Bio-Path Holdings Provides Update From Phase 1/1B Clinical Trial Of Bp1002 For Treatment Of Refractory/Relapsed Acute Myeloid Leukemia
Bio-Path rises on positive preclinical data for obesity treatment
Bio Path Holdings Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Bio-Path Q3 EPS USD -0.7
Bio Path Holdings Inc expected to post a loss of $1.02 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Peabody Energy, Snowflake, Toll Brothers
U.S. STOCKS ON THE MOVE-Hyatt, Peabody Energy, Snowflake
U.S. STOCKS ON THE MOVE-Analog Devices, TJX, Texas Instruments
Bio-Path rises as experimental cancer drugs show promise in ongoing trials
Bio Path Holdings Inc reports results for the quarter ended in June - Earnings Summary
Brief: Bio-Path Q2 EPS USD -1.16
Bio Path Holdings Inc expected to post a loss of $1.54 a share - Earnings Preview
Brief: Bio-Path Holdings Provides Clinical Update And Expansion Plans
Advisory: Alert from FN Media Group wrongly tagged to multiple companies withdrawn
Brief: Bio Path Holdings Inc - Got Nasdaq Letter Granting Extension Until September 8 To Demonstrate Compliance With Stockholders' Equity Requirement
Brief: Bio Path Holdings Inc Files Prospectus Related To Offering Of Up To 5.6 Million Shares Of Common Stock By Selling Stockholders - SEC Filing